Literature DB >> 4248929

Dopamine and disease.

A Barbeau.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4248929      PMCID: PMC1930531     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  53 in total

1.  EFFECT OF DOPAMINE IN MAN: AUGMENTATION OF SODIUM EXCRETION, GLOMERULAR FILTRATION RATE, AND RENAL PLASMA FLOW.

Authors:  R H MCDONALD; L I GOLDBERG; J L MCNAY; E P TUTTLE
Journal:  J Clin Invest       Date:  1964-06       Impact factor: 14.808

2.  The occurrence, distribution and physiological role of catecholamines in the nervous system.

Authors:  A CARLSSON
Journal:  Pharmacol Rev       Date:  1959-06       Impact factor: 25.468

3.  3',5' cyclic adenosine monophosphate in depression and mania.

Authors:  Y H Abdulla; K Hamadah
Journal:  Lancet       Date:  1970-02-21       Impact factor: 79.321

4.  Effect of L-DOPA on depression.

Authors:  W E Bunney; D S Janowsky; F K Goodwin; J M Davis; H K Brodie; D L Murphy; T N Chase
Journal:  Lancet       Date:  1969-04-26       Impact factor: 79.321

Review 5.  The catecholamine hypothesis of affective disorders: a review of supporting evidence.

Authors:  J J Schildkraut
Journal:  Am J Psychiatry       Date:  1965-11       Impact factor: 18.112

6.  Is there an interaction between dopamine and noradrenaline containing neurons in the brain?

Authors:  T Persson; B Waldeck
Journal:  Acta Physiol Scand       Date:  1970-01

7.  Dopamine excretion in affective states and following Li2Co3 therapy.

Authors:  F S Messiha; D Agallianos; C Clower
Journal:  Nature       Date:  1970-02-28       Impact factor: 49.962

8.  Treatment of parkinsonism with levodopa.

Authors:  M D Yahr; R C Duvoisin; M J Schear; R E Barrett; M M Hoehn
Journal:  Arch Neurol       Date:  1969-10

9.  Changing concepts of the asthma problem.

Authors:  M Dworetzky
Journal:  J Allergy       Date:  1969-06

10.  Alkaloids from catecholamines in adrenal tissue: possible role in alcoholism.

Authors:  G Cohen; M Collins
Journal:  Science       Date:  1970-03-27       Impact factor: 47.728

View more
  10 in total

1.  [Differential treatment of Parkinson's disease, with special reference to the possibility of iatrogenic disorders (author's transl)].

Authors:  W Gehlen
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1974-04-09

2.  [Comparison of the effect of L-Dopa and of an L-Dopa+decarboxylase inhibitor combination in Parkinson's disease].

Authors:  E Schneider; P A Fischer; P Jacobi; H Maxion
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1973-03-19

3.  [The therapeutic effect of L-dopa].

Authors:  P Groneberg; A Struppler
Journal:  Naturwissenschaften       Date:  1972-11

4.  The catecholaminergic neurotransmitter system in methylmercury-induced neurotoxicity.

Authors:  Marcelo Farina; Michael Aschner; João Batista Teixeira da Rocha
Journal:  Adv Neurotoxicol       Date:  2017-09-01

5.  A double-blind trial of bromocriptine in steroid dependent asthma.

Authors:  K M Christensen; H Letman; A G Mikkelsen
Journal:  Thorax       Date:  1979-04       Impact factor: 9.139

6.  Idiopathic orthostatic hypotension treated with levodopa and MAO inhibitor: a preliminary report.

Authors:  J Sharpe; A Marquez-Julio; P Ashby
Journal:  Can Med Assoc J       Date:  1972-08-19       Impact factor: 8.262

7.  Rapid dopaminergic modulation of the fish hypothalamic transcriptome and proteome.

Authors:  Jason T Popesku; Christopher J Martyniuk; Nancy D Denslow; Vance L Trudeau
Journal:  PLoS One       Date:  2010-08-20       Impact factor: 3.240

8.  Electrophysiological Actions of Synthetic Cathinones on Monoamine Transporters.

Authors:  Ernesto Solis
Journal:  Curr Top Behav Neurosci       Date:  2017

9.  Levodopa combined with peripheral decarboxylase inhibition in Parkinson's disease.

Authors:  A Barbeau; H Mars; M I Botez; M Joubert
Journal:  Can Med Assoc J       Date:  1972-06-10       Impact factor: 8.262

Review 10.  Psoriasis and neurodegenerative diseases-a review.

Authors:  Julia Nowowiejska; Anna Baran; Iwona Flisiak
Journal:  Front Mol Neurosci       Date:  2022-09-26       Impact factor: 6.261

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.